Stay updated on Intratumoral SD-101 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral SD-101 + Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Non-substantive UI and text adjustments were observed; the core study details (title, conditions, eligibility, primary/secondary outcomes) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-30T11:53:12.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Added v3.2.0 update; removed a specific resource (Head and neck squamous cell carcinoma) and removed v3.0.2.
    Difference
    0.3%
    Check dated 2025-10-01T05:18:16.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Updated version to v3.1.0 and removed the resource on head and neck squamous cell carcinoma.
    Difference
    0.3%
    Check dated 2025-09-30T03:40:34.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2, replacing v3.0.1, indicating a new release. The 'Back to Top' navigation element was removed.
    Difference
    0.1%
    Check dated 2025-09-15T19:28:04.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-08T15:08:03.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated to include new resources related to head and neck cancer and specific locations in Germany, while removing previous references to other cancer types and locations.
    Difference
    2%
    Check dated 2025-09-01T09:38:35.000Z thumbnail image

Stay in the know with updates to Intratumoral SD-101 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.